KEGG: bhe:BH04110
STRING: 283166.BH04110
ATP synthase subunit a (atpB) in Bartonella henselae functions as a critical component of the F₀ portion of the F₁F₀-ATP synthase complex, facilitating proton translocation across the bacterial membrane. This protein plays an essential role in energy production through oxidative phosphorylation, allowing B. henselae to generate ATP for cellular processes. The protein is particularly important during the transition between arthropod vector and mammalian host environments, where energy demands fluctuate substantially. Like other intracellular pathogens, B. henselae must adapt its energy metabolism to survive within host cells, making atpB a potentially important factor in its persistence during infection .
Recombinant B. henselae ATP synthase subunit a (atpB) is produced through heterologous expression systems, typically in E. coli, following similar methods to those used for other Bartonella proteins. The recombinant protein generally maintains the primary sequence of native atpB but may include affinity tags (such as His-tags) to facilitate purification. While the core structure remains intact, recombinant atpB may exhibit differences in post-translational modifications compared to the native form. These differences should be considered when using recombinant atpB for structural studies or functional assays, as they might affect protein folding or activity. Expression systems similar to those used for other Bartonella proteins, like the pET expression system employed for BafA protein domains, are typically utilized for atpB production .
Recombinant B. henselae atpB should be stored following protocols similar to other bacterial membrane proteins. For short-term storage (1-2 weeks), the protein can be maintained at 4°C in an appropriate buffer system containing stabilizing agents. For long-term storage, aliquoting the protein and storing at -80°C is recommended to prevent freeze-thaw damage. The addition of glycerol (10-15%) can help maintain protein stability during freezing. Proper buffer selection is crucial, typically phosphate-buffered saline (PBS) at pH 7.4 with potential additions of reducing agents like DTT or β-mercaptoethanol if the protein contains critical cysteine residues. When preparing the protein for experimental use, it's important to maintain the protein in conditions that preserve its native conformation and prevent aggregation.
The most effective expression systems for producing recombinant B. henselae atpB typically involve E. coli strains optimized for membrane protein expression. The pET expression system with BL21(DE3) or C41(DE3)/C43(DE3) E. coli strains (which are better suited for membrane protein expression) often yields satisfactory results. For atpB production, researchers should consider approaches similar to those used for other Bartonella proteins, where specific vectors like pET-28b have been successfully employed for expressing protein domains . The expression protocol typically involves:
Cloning the atpB gene into an appropriate expression vector with a suitable tag (His-tag or Strep-tag)
Transformation into an expression host
Induction with IPTG at reduced temperatures (16-25°C) to enhance proper folding
Extended expression periods (overnight to 24 hours)
Careful membrane fraction isolation followed by detergent solubilization
The choice of detergent is critical for maintaining protein stability and functionality, with mild non-ionic detergents like DDM (n-dodecyl-β-D-maltoside) often preferred for ATP synthase components.
Purification of recombinant B. henselae atpB typically follows a multi-step chromatography approach. The recommended purification strategy includes:
Affinity chromatography as the initial capture step (Ni-NTA for His-tagged proteins or Strep-Tactin for Strep-tagged proteins)
Ion exchange chromatography as an intermediate purification step
Size exclusion chromatography as a final polishing step
Throughout the purification process, the protein should be maintained in a buffer containing an appropriate detergent above its critical micelle concentration to prevent aggregation. A typical purification workflow might resemble that used for other Bartonella membrane proteins, employing methods similar to those used for purifying BafA protein . The addition of stabilizing agents such as glycerol (10%) and careful pH control are essential for maintaining protein integrity during purification. Yield and purity should be assessed at each step using SDS-PAGE and Western blotting with antibodies specific to the target protein or the affinity tag.
Verifying the structural integrity of purified recombinant B. henselae atpB requires a combination of biophysical and biochemical approaches:
Circular Dichroism (CD) spectroscopy to assess secondary structure content
Thermal shift assays to evaluate protein stability
Limited proteolysis to examine folding quality
Size exclusion chromatography coupled with multi-angle light scattering (SEC-MALS) to confirm proper oligomeric state
Functional assays measuring ATP hydrolysis activity (in reconstituted systems)
Native-PAGE or Blue Native-PAGE can provide information about the assembly state of the protein. For membrane proteins like atpB, reconstitution into liposomes or nanodiscs followed by proton translocation assays may be necessary to confirm functional integrity. When analyzing recombinant atpB, researchers should compare results to known properties of ATP synthase subunits from related bacteria to identify potential structural abnormalities that might affect experimental outcomes.
Recombinant B. henselae atpB serves as a valuable tool in structural biology studies focused on understanding the architecture and function of bacterial ATP synthases. Researchers employ the following approaches:
For successful structural studies, researchers must optimize detergent conditions or consider reconstitution into membrane mimetics like nanodiscs or amphipols. When studying atpB in isolation, it's important to consider that its native conformation may depend on interactions with other ATP synthase subunits. Therefore, co-expression or reconstitution with partner subunits might be necessary for obtaining physiologically relevant structural data. Similar approaches have been used successfully with other Bartonella membrane proteins .
Recombinant B. henselae atpB has potential applications in developing serological diagnostic tools for Bartonella infections, following similar principles to those established for other Bartonella antigens like Pap31. The development process typically involves:
Evaluation of recombinant atpB's antigenicity using patient sera
Assessment of sensitivity and specificity in ELISA or Western blot formats
Comparison with existing diagnostic antigens
Validation with clinically confirmed samples
Researchers have successfully used recombinant Bartonella proteins in ELISA formats with excellent discrimination between positive and negative patient samples, as demonstrated with Pap31 . Similar approaches could be applied to atpB if it proves to be immunogenic during B. henselae infections. The development of rapid diagnostic tests using recombinant atpB would follow protocols similar to those established for other Bartonella antigens, potentially addressing the need for improved diagnostic tools for bartonellosis in both clinical and research settings.
Researchers can employ recombinant B. henselae atpB to investigate the bacterium's energy metabolism adaptations during infection through several experimental approaches:
Gene expression studies using qRT-PCR to monitor atpB expression levels under different infection conditions
Protein-protein interaction studies to identify regulatory partners
Site-directed mutagenesis to create atpB variants for functional studies
Development of atpB-specific antibodies for immunolocalization during infection
By combining these approaches with infection models, researchers can determine how B. henselae modulates ATP synthesis during different stages of infection. Particularly interesting is how the bacterium adapts its energy metabolism when transitioning between the arthropod vector and mammalian host, or when exposed to host defense mechanisms. Understanding these adaptations could reveal how B. henselae persists in host cells and potentially identify new targets for therapeutic intervention. Similar approaches have been used to study other Bartonella virulence factors, such as the BatR/BatS two-component regulatory system that helps the bacterium respond to environmental pH changes during infection .
ATP synthase subunit a (atpB) likely plays a critical role in B. henselae's adaptation to varying host environments through modulation of energy production. In the context of the bacterium's complex lifecycle involving arthropod vectors and mammalian hosts, atpB may function as:
A responsive element in the bacterium's pH-sensing network, potentially regulated by the BatR/BatS two-component system that serves as a pH sensor in Bartonella
A component of the adaptive response to different oxygen tensions encountered in various host niches
A participant in metabolic reprogramming during transitions between host environments
The regulation of ATP synthase components appears to be an important aspect of bacterial adaptation to host environments. B. henselae likely modulates atpB expression or activity to optimize energy production under different conditions, such as the neutral pH of mammalian blood versus the potentially more alkaline environment of arthropod vectors. This adaptation mechanism would be consistent with the known pH-responsive regulation systems in Bartonella, where genes are upregulated at neutral pH and repressed at alkaline pH .
The proton translocation function of atpB depends on specific structural features that can be investigated through detailed molecular approaches:
Conserved transmembrane helices that form part of the proton channel
Critical charged residues (particularly arginine and aspartate) that participate in proton transfer
Specific interactions with other F₀ subunits (particularly subunit c)
To study these features, researchers can employ:
| Approach | Information Obtained | Technical Considerations |
|---|---|---|
| Site-directed mutagenesis | Functional importance of specific residues | Requires functional reconstitution system |
| Hydrogen-deuterium exchange mass spectrometry | Solvent accessibility and dynamics | Requires specialized equipment and expertise |
| Molecular dynamics simulations | Dynamic behavior of proton path | Relies on accurate structural models |
| Cross-linking studies | Subunit interfaces and interactions | Requires optimization of cross-linking conditions |
Understanding the structural basis of atpB's proton translocation is complicated by the protein's membrane-embedded nature and its functional dependence on other ATP synthase components. Therefore, studies often need to consider the ATP synthase complex as a whole rather than atpB in isolation. Advanced structural techniques similar to those used for other membrane proteins in Bartonella could provide insights into atpB's functional mechanisms .
The interactions between atpB and other ATP synthase components in B. henselae form the foundation of a functional F₁F₀-ATP synthase complex. These interactions can be characterized using:
Co-immunoprecipitation assays with tagged atpB to identify interacting partners
Bacterial two-hybrid systems to screen for specific protein-protein interactions
Cross-linking mass spectrometry to map interaction interfaces
Reconstitution studies with purified components to assess functional interactions
AtpB likely interacts primarily with the c-ring of the F₀ sector and forms part of the stator that connects to the F₁ sector through interactions with subunits b and δ. These interactions are essential for coupling proton translocation to ATP synthesis. The methodologies for studying these interactions would be similar to those used for investigating other protein complexes in Bartonella, such as the approaches used to study the VirB/VirD4 T4SS complex components . Understanding these interactions could provide insights into the assembly and regulation of the ATP synthase complex in B. henselae and potentially reveal unique features that might be exploited for targeted interventions.
B. henselae atpB shares structural and functional similarities with homologous proteins in other pathogenic bacteria, but also exhibits species-specific characteristics:
| Bacterial Species | atpB Similarity | Functional Differences | Evolutionary Implications |
|---|---|---|---|
| Escherichia coli | High sequence conservation in functional domains | Well-characterized, benchmark for comparison | Conserved core function across diverse bacteria |
| Other Bartonella species (e.g., B. quintana) | Very high sequence identity (>90%) | Similar adaptations to host environments | Recent divergence within genus |
| Brucella species | Moderate to high sequence similarity | Similar intracellular lifestyle requirements | Common adaptations in related α-proteobacteria |
| Rickettsia species | Moderate sequence similarity | Highly reduced genome, specialized metabolism | Parallel adaptations to intracellular lifestyle |
While B. henselae and B. quintana are closely related species with similar lifestyles, their atpB proteins may exhibit subtle functional differences reflecting their distinct host preferences and ecological niches:
These differences may contribute to the distinct pathogenicity profiles of these two Bartonella species. B. henselae primarily infects cats and causes cat scratch disease in humans, while B. quintana is adapted to human hosts and causes trench fever. Research approaches similar to those used to compare other proteins between these species, such as the comparative analysis of BafA proteins that revealed similar angiogenic activities despite sequence differences , would be valuable for understanding species-specific adaptations in energy metabolism.
While atpB's primary function relates to energy metabolism, it may contribute to B. henselae pathogenicity through several mechanisms:
Supporting bacterial survival during host cell invasion and intracellular persistence
Maintaining energy homeostasis during stress conditions encountered within the host
Potentially contributing to membrane potential maintenance, which may influence other virulence mechanisms
Possibly participating in pH adaptation during host cell infection
ATP synthase components represent potential targets for antimicrobial development due to their essential role in bacterial energy metabolism. Several factors support considering atpB as a therapeutic target:
Essential function: Disruption of ATP synthesis would severely compromise bacterial survival
Accessibility: The F₀ sector of ATP synthase is embedded in the bacterial membrane
Structural differences: Despite conservation, bacterial ATP synthases differ sufficiently from human counterparts to allow selective targeting
Research approaches to explore atpB as a therapeutic target include:
| Approach | Description | Potential Outcomes |
|---|---|---|
| High-throughput screening | Testing compound libraries for inhibition of ATP synthase activity | Identification of hit compounds for further development |
| Structure-based drug design | Using structural information to design specific inhibitors | Rationally designed inhibitors with improved specificity |
| Peptide inhibitors | Development of peptides that disrupt atpB interactions | Potentially specific inhibitors that block assembly or function |
| Immunotherapy | Using atpB as a target for antibody-based therapies | Possible approach for extracellular bacteria or exposed epitopes |